• AIDX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • Price change

    The price of AIDX shares has decreased $0.08 since the market last closed. This is a 8.75% drop.

  • Closed at $0.87.

    The stock has since risen $0.03 in after-hours trading.

Key terms

About AIDX

20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
  • Market cap: $10.08M

    A market capitalization up to $300 million places AIDX in the micro-capitalization category.

Key terms

Smart score

Latest AIDX news

May 22, 2026 3:55pm ET 20/20 Biolabs: Buy Rating Reiterated on Growth Outlook and OneTest Momentum; $5 Price Target Maintained by TipRanks May 22, 2026 8:48am ET 20/20 BioLabs develops contingency plans to establish Ebola, Hantavirus by TipRanks May 12, 2026 10:02am ET 20/20 BioLabs enters licensing agreement with University of South Carolina by TipRanks May 11, 2026 11:28am ET 20/20 BioLabs initiated with a Buy at Maxim by TipRanks May 08, 2026 12:50pm ET Analysts Are Bullish on Top Healthcare Stocks: Pacific Biosciences (PACB), 20/20 Biolabs, Inc. (AIDX) by TipRanks Apr 06, 2026 5:35pm ET 20/20 BioLabs files to sell 10.1M shares of common stock for holders by TipRanks Mar 27, 2026 8:57am ET 20/20 BioLabs announces grants for Maryland fire departments to procure OneTest by TipRanks Mar 24, 2026 8:46am ET 20/20 BioLabs enters exclusive technology license, access agreement with Rokit by TipRanks Mar 23, 2026 4:50pm ET Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH) and 20/20 Biolabs, Inc. (AIDX) by TipRanks Mar 20, 2026 2:10pm ET Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Cingulate Inc (CING) by TipRanks Mar 16, 2026 11:10am ET Opening Day: SoftBank payments app operator makes public debut by TipRanks Mar 12, 2026 8:50am ET 20/20 BioLabs provides update on protein biomarket technology for MCED by TipRanks Mar 11, 2026 12:10pm ET Analysts Offer Insights on Healthcare Companies: 20/20 Biolabs, Inc. (AIDX) and Biogen (BIIB) by TipRanks Feb 25, 2026 10:10am ET 20/20 Biolabs, Inc. Common Stock trading resumes by TipRanks Feb 25, 2026 10:00am ET 20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause by TipRanks Feb 25, 2026 8:54am ET 20/20 BioLabs announces launch, commercial availability of OneTest by TipRanks Feb 23, 2026 11:10am ET Opening Day: Three AI-focused newcomers make market debuts by TipRanks Feb 23, 2026 9:40am ET 20/20 Biolabs, Inc. Common Stock trading resumes by TipRanks Feb 23, 2026 9:35am ET 20/20 Biolabs, Inc. Common Stock trading halted, volatility trading pause by TipRanks
May 27, 2026 8:31am ET 20/20 Biolabs' Multi-Cancer Early Detection Blood Test Selected by State of Vermont to Screen up to 4,500 Firefighters by GlobeNewswire May 22, 2026 8:31am ET 20/20 Biolabs Commences Emergency Planning for Ebola & Hantavirus Lab Testing if Outbreak Creates Overflow Demand by GlobeNewswire May 20, 2026 4:05pm ET 20/20 BioLabs Reports First Quarter 2026 Financial Results and Recent Operational Progress by GlobeNewswire May 14, 2026 8:31am ET 20/20 BioLabs to Attend Sidoti Micro-Cap Virtual Conference on May 20, 2026 by GlobeNewswire May 12, 2026 8:31am ET 20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm from the University of South Carolina by GlobeNewswire Apr 07, 2026 8:31am ET 20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform by GlobeNewswire Mar 31, 2026 4:57pm ET 20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress by GlobeNewswire Mar 27, 2026 8:31am ET Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test by GlobeNewswire Mar 24, 2026 8:31am ET 20/20 BioLabs Announces Exclusive U.S. License Agreement with ROKIT Healthcare to Integrate Advanced CKD Prediction Technology into Its Longevity Test Program by GlobeNewswire Mar 12, 2026 8:31am ET 20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies by GlobeNewswire Feb 25, 2026 8:31am ET 20/20 BioLabs Launches OneTest for Longevity Blood Test and Chronic Disease Risk Assessment and Management Solution Built with IBM AI Capabilities by GlobeNewswire Feb 20, 2026 8:31am ET 20/20 BioLabs to Host Virtual Investor Webinar on Thursday, February 26, 2026 at 2:00 p.m. Eastern Time by GlobeNewswire

AIDX Financials

1-year income & revenue

  • AIDX total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • AIDX net income: currently unavailable. Sorry, we currently don't have enough data to create an insight.

  • AIDX earnings per share: currently unavailable. Sorry, we currently don't have enough data to create an insight.

Key terms

AIDX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

AIDX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range
  • How competitors are chosen

    AIDX's competitors are included in the Health Services sector and Medical/Nursing Services group

  • Market cap: $10.08M

    A market capitalization up to $300 million places AIDX in the micro-capitalization category.

Key terms

Latest investing news